Benjamin Graham · Investimento deep-value defensivo
Is Regeneron Pharmaceuticals, Inc. (REGN) a Benjamin Graham Stock?
Meets 3/7 Graham criteria, partially qualifies.
66/100
Misto
3/7 critérios atendidos
Os critérios de Benjamin Graham, aplicados a REGN
P/E ≤ 15
chave16.4x
P/B ≤ 1.5
chave2.3x
Current ratio ≥ 2
3.6x
Debt / Equity ≤ 1
0.1x
Como REGN pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$75.69B
P/L (TTM)
16.4x
ROIC (TTM)
8.53%
Margem bruta
84.55%
Outras análises Benjamin Graham
Perguntas frequentes
What is REGN's Benjamin Graham fit score?
REGN scores 66/100 on our Benjamin Graham fit engine. Meets 3/7 Graham criteria, partially qualifies.
Does Benjamin Graham actually own REGN?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends REGN.
How often is this score updated?
REGN's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Benjamin Graham possua ou recomende REGN pessoalmente.
